wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38922396-FFBCB414-2C17-428F-99CE-1163C474DD1A
Q38922396-FFBCB414-2C17-428F-99CE-1163C474DD1A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38922396-FFBCB414-2C17-428F-99CE-1163C474DD1A
Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.
P2860
Q38922396-FFBCB414-2C17-428F-99CE-1163C474DD1A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38922396-FFBCB414-2C17-428F-99CE-1163C474DD1A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e6ec57a771d5a5fef8d0d3a2b60b47b6ec701378
P2860
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].